Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02658968
Title Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nordic Nanovector
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | DEU

Facility Status City State Zip Country Details
University of California, San Diego (UCSD) - Moores Cancer Center San Diego California 92093 United States Details
University of California, San Francisco (UCSF) - Innovation, Technology & Alliances San Francisco California 94117 United States Details
Sylvester Comprehensive Cancer Centre Miami Florida 33146 United States Details
Klinikum rechts der Isar der TU München Munich 81675 Germany Details
Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi Bologna 40138 Italy Details
Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino Torino 10126 Italy Details
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento Verona 37134 Italy Details
Hospital Universitari i Politècnic La Fe Valencia 46026 Spain Details
University Hospitals Bristol NHS Foundation Trust - Bristol Haematology and Oncology Centre Bristol BS2 8ED United Kingdom Details
Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field